Pharmaceutical Technology56m
Jazz Pharmaceuticals bids for Chimerix in $935m deal
The deal, disclosed on Wednesday 5 March, will see Jazz pay $8.55 per share, representing a 72.4% premium to Chimerix’s 4 ...
Pharmaceutical Technology2h
Indonesia approves Antengene’s Xpovio NDA for multiple indications
Antengene’s Xpovio NDA has gained approval from the Indonesia National Agency of Drug and Food Control for three indications.
Pharmaceutical Technology1h
Container Closure Integrity Testing (CCIT): What you need to know
Container Closure Integrity Testing (CCIT) is a critical quality check for pharmaceuticals. In this article we give a brief ...
Pharmaceutical Technology6h
WuXi Biologics introduces E coli expression system
WuXi Biologics has launched the E. coli expression system, EffiX, designed to enhance the production of recombinant proteins ...
Pharmaceutical Technology6h
Asceneuron halts Alzheimer’s trial adding to tau-targeting setbacks
Asceneuron is the latest biotech to face setbacks in developing tau-targeting therapies for Alzheimer’s. After Eli Lilly and ...
Pharmaceutical Technology9h
FDA approves BeiGene’s Tevimbra plus chemo for oesophageal cancer
The US Food and Drug Administration (FDA) has approved BeiGene’s Tevimbra (tislelizumab-jsgr) along with platinum-containing ...